BMO Capital analyst Jack Matten raised the firm’s price target on Globe Life (GL) to $149 from $114 and keeps a Market Perform rating on the shares after its Q2 results. The firm cites the company’s positive underlying trends at its Direct to Consumer arm which helps exclusive agency sales via leads+analytics, along with the removal of a valuation overhang from inquiries and investigations, the analyst tells investors in a research note. The stock’s valuation also still embeds some discount versus long-term averages, BMO added.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GL:
- Positive Regulatory Outcomes Reinforce Buy Rating for Globe Life
- Globe Life price target raised to $160 from $155 at Keefe Bruyette
- Early notable gainers among liquid option names on July 29th
- Globe Life Cleared by DOJ and SEC Investigations
- Globe Life announces closing of Department of Justice investigation